COVID-19 in an Adult With Tricuspid Atresia S/P Fontan Palliation
In December 2019, a pathogenic novel human coronavirus (HCoV), termed SARS-CoV-2, was recognized in Wuhan, China, causing significant morbidity and mortality. The illness caused by SARS-CoV-2 is labelled coronavirus disease-2019 (COVID-19) by the World Health Organization. We report the first case o...
Main Authors: | Neha Ahluwalia, MD, Barry Love, MD, Alice Chan, Ali N. Zaidi, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | JACC: Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666084920304769 |
Similar Items
-
Cirugía de la válvula tricúspide
by: Juan Carlos Bahamondes
Published: (2022-05-01) -
Optimal Tricuspid Annular Size for Tricuspid Annuloplasty in Patients with Less-Than-Moderate Functional Tricuspid Regurgitation
by: Jae Woong Choi, et al.
Published: (2020-12-01) -
Tricuspid Stenosis in Pregnancy
by: Oluwayemisi L. Adejumo, MD, et al.
Published: (2020-11-01) -
Late Clinical Outcomes of the Fontan Operation in Patients with Tricuspid Atresia
by: Eduardo T. Mastalir, et al.
Published: (2002-07-01) -
Determinants of Morbidity and Mortality Associated With Isolated Tricuspid Valve Surgery
by: Akram Kawsara, et al.
Published: (2021-01-01)